CMV IgG

In vitro diagnostic medical device for assisting in the screening of CMV infection

CMV remains latent in the body for life after infection. While it usually causes no significant symptoms in healthy individuals, it can reactivate and cause complications when the immune system is weakened. Pregnant women may experience little to no symptoms, but the virus can be transmitted to the fetus through the placenta, potentially leading to miscarriage, stillbirth, or congenital infection such as hearing loss. Additionally, CMV poses a significant risk during blood transfusions and organ transplants, making it a critical consideration.